Impact of Hydrogel Spacer Insertion on Radiation Dose to Erectile Structures and Longitudinal Sexual Function in Prostate Cancer Patients
Open Access
Abstract
Background: Erectile dysfunction is a common late effect of prostate radiotherapy. Hydrogel spacers aim to reduce radiation exposure to nearby structures by increasing the distance between the prostate and surrounding tissues, potentially preserving sexual function. Methods: In this retrospective cohort study of 117 prostate cancer patients who received hydrogel spacers, we compared pre- and post-insertion radiation dose and anatomical positioning of erectile structures using paired t-tests. Longitudinal sexual function, assessed via EPIC scores, was modeled using linear mixed-effects regression with natural splines (df = 3), incorporating random intercepts and slopes to account for within-subject variability. Results: Spacer insertion significantly reduced radiation dose to the left and right neurovascular bundles (mean reductions: 1.66 Gy, 95% CI: 1.32–2.00; and 1.64 Gy, 95% CI: 1.28–2.01, respectively; p < 0.01) and the right perineal artery (1.33 Gy, 95% CI: 0.57–2.09; p < 0.01). No significant dose changes were observed for the penile bulb or left perineal artery, nor in anatomical distances. However, spatial displacement was confirmed by significant overlap and integrated volume changes. Longitudinal modeling showed a significant decline in sexual function between 12 and ≥36 months post-treatment (Spline 2: β = –12.72, 95% CI: −18.52–−6.92 and Spline 3: β = –6.68, 95% CI: −10.96–−2.40; p < 0.01). Conclusions: Hydrogel spacer insertion was associated with significant reductions in radiation dose to erectile structures, most notably the neurovascular bundles and the right perineal artery. However, longitudinal analyses revealed no corresponding preservation of sexual function. These findings suggest that while hydrogel spacers effectively reduce radiation exposure to key anatomical structures, their clinical benefit for maintaining erectile function remains uncertain.Keywords
Funding Information
- National Cancer Institute of the National Institutes of Health (R37CA229417)
This publication has 32 references indexed in Scilit:
- Association Between Rectal Spacer Use and Erectile Dysfunction Diagnosis Among Men Receiving Prostate Radiotherapy: US County‐Level AnalysisCancer Medicine, 2025
- Stereotactic radiotherapy for prostate cancerCancer/Radiothérapie, 2025
- Challenges and opportunities to minimize the dose in the neurovascular bundles during prostate radiotherapyClinical and Translational Radiation Oncology, 2025
- One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancerWorld Journal of Urology, 2024
- An optimal method of hydrogel spacer insertion for stereotactic body radiation therapy of prostate cancerJapanese Journal of Radiology, 2023
- Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic ReviewEuropean Urology Oncology, 2022
- Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatmentClinical and Translational Radiation Oncology, 2022
- The expanded prostate cancer index composite short form (EPIC-26) for measuring health-related quality of life: content analysis of patients’ spontaneous comments written in survey marginsQuality of Life Research, 2021
- FEMOSSA: Patient‐specific finite element simulation of the prostate–rectum spacer placement, a predictive model for prostate cancer radiotherapyMedical Physics, 2021
- Radiation-induced erectile dysfunction: Recent advances and future directionsAdvances in Radiation Oncology, 2016